Takeda joins CAR-T competition with Noile-Immune alliance
With CAR-T therapies reaching the market, Japanese drugmaker Takeda has made a bid to get in on the action with a deal with biotech startup Noile-Immune. The agreement gives Takeda a line into the work of Professor Koji Tamada at Yamaguchi University in Japan, who is a founder and chief scientific and medical officer at